Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer
about
Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting of interleukin (IL)- ...... murine model of breast cancer
@en
Targeting of interleukin
@nl
type
label
Targeting of interleukin (IL)- ...... murine model of breast cancer
@en
Targeting of interleukin
@nl
prefLabel
Targeting of interleukin (IL)- ...... murine model of breast cancer
@en
Targeting of interleukin
@nl
P2093
P2860
P356
P1433
P1476
Targeting of interleukin (IL)- ...... murine model of breast cancer
@en
P2093
Dongqing Li
Yanhong Ji
Yun-Feng Ma
Zhuang-Wei Lv
P2860
P304
P356
10.18632/ONCOTARGET.13819
P407
P577
2016-12-07T00:00:00Z